BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2022
Biohit Oyj Financial Statement Release 15 February 2023 at 9:30 am local time (EET) SUMMARY January-December 2022 · Revenue EUR 11.0 million (EUR 9.4 million) · Revenue grew by 17.0% compared to 2021 · Operative EBITDA EUR +1.8 million (EUR 0,5 million) · Cash at the end of the period EUR 2.1 million (EUR 1.1 million) · Fair value of Genetic Analysis AS investment EUR 0.3 million (EUR 0.9 million 31 December 2021) · Revenue from international operations 97.9% (97.5%) of total revenue · Equity ratio 68.3% (76.3%) July-December 2022 · Revenue EUR 4.8